Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.
Gene manipulation can revert the cardiomyocytes back to a fetal state, allowing them to regenerate. Researchers are now looking for drugs to mimic the effect.
Three patient deaths, 31 injuries and 322 complaints led to an FDA Class 1 recall of Teleflex/Arrow International intra-aortic balloon pump (IABP) catheter kits.
Drawing inspiration from the World War II “Why We Fight” campaign that rallied support for the U.S. war effort, AMA President Jesse Ehrenfeld, MD, spoke on the uphill battles physicians are facing today.
Connolly spent 40 years at McMaster University as a professor and researcher, founding the school’s cardiac arrhythmia service line and serving as its cardiology chair. He remained active in electrophysiology research until the end of his life.
Paul Zei, MD, discusses late-breaking data from the REAL-AF Registry, which looked at the short- and long-term outcomes of radiofrequency ablation in paroxysmal and persistent atrial fibrillation.
Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."
